NEWS

Pursuit of tumor-infiltrating lymphocyte immunotherapy speeds up

Mounting evidence of efficacy in metastatic breast cancer and other epithelial tumors is driving clinical and commercial investment in tumor-infiltrating lymphocytes.
Ann Arbor, Michigan, USA.

Search for this author in:

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Nature Biotechnology 37, 969-971 (2019)

doi: 10.1038/d41587-019-00023-6

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.